Table 1. Characteristics of study subjects.
BC Cases N (%) | Controls N (%) | Total N. (%) | |
---|---|---|---|
Total | 142 (100) | 239 (100) | 381 (100) |
Age | |||
mean (range) | 56 (34–79) | 48 (18–72) | 51 (18–79) |
<40 | 9 (6.4) | 53 (22.2) | 62 (16.3) |
40–55 | 49 (34.5) | 126 (52.7) | 175 (45.9) |
55–65 | 57 (40.1) | 43 (18.0) | 100 (26.2) |
>65 | 27 (19.0) | 17 (7.1) | 44 (11.6) |
Family history | |||
1st degree | 55 (38.8) | 85 (35.6) | 140 (36.7) |
2nd | 26 (18.3) | 49 (20.5) | 75 (19.7) |
Neg/>2nd | 61 (42.9) | 105 (43.9) | 166 (43.6) |
BRCA classes | |||
Pathogenic variant BRCA1 | 12 (8.5) | 8 (3.3) | 20 (5.3) |
Pathogenic variant BRCA2 | 5 (3.5) | 3 (1.2) | 8 (2.1) |
VUS BRCA1 | 5 (3.5) | 2 (0.8) | 7 (1.8) |
VUS BRCA2 | 10 (7.0) | 3 (1.2) | 13 (3.4) |
Negative test | 43 (30.3) | 29 (12.1) | 72 (18.9) |
NA | 67 (47.2) | 194 (81.3) | 261 (68.5) |
NA not available